Embedded Files
March 6th, 2025
Dr. Zhang hosts a Biomedical science conference at NYITCOM " AI in Medicine, Education, and Cancer Diagnostics". Last year's summer students, Muhammed Celebi, Samantha Juang, Christopher Tong, and Derin Ibrahim Yetil presented their research posters as well.
January 1st, 2025
We welcome Dr. Zhang's Scholar student, Shakir Naji, to the lab.
November 7th, 2024:
Dr. Zhang, Dr. Plummer and NYITCOM host its second annual NYIT-Center of Cancer Research and the Cancer Institute of Catholic Health Research Symposium.
May 24th, 2024:
Dr. Zhang's D.O/Ph.D.candidate student Manrose (Manny) Singh gave his dissertation on his thesis "Elucidation of the Molecular Mechanism of the Breakage-Fusion-Bridge (BFB) Cycle Using a CRISPR-dCas9 Cellular Model" and successful passed his defense. Congrats to our new Doctor, Manny Singh Ph.D.! He will now go on to do his rotations this upcoming July.
May 19th, 2024:
We are so proud of the Class of 2024 who were hooded, especially to Sanket Desai! Wishing them the best luck in their next chapter!
April 8th, 2024:
We welcome our new lab technician Liam Buchanan B.S., to the lab.
January 11th, 2024:
Our former lab technician, Alexis M. Perez leaves our lab to become a Science teacher in PA. We wish her the best of luck on her future endeavors and give thanks for her dedication to our lab.
August 9th, 2023:
Dr. Zhang's D.O/Ph.D. student, Ashwin Ragupathi, passed his Dissertation proposal.
June 16, 2023:
Dr. Zhang and his colleagues at Drexel University published an article regarding identifying ALT positivity Cancer through an single-molecule telomere assay in optical mapping.
May 20th, 2023:
We are so proud of the Class of 2023 who were hooded, especially Katherine Loomba and Julie To Cherry! Wishing them the best luck in their next chapter!
NYIT had a 100% Match Rate this year, with all the students of the Class of 2023 placed into residencies! The Zhang Lab would like to celebrate the following in their matches:
Rama Hussein matched with Internal Medicine at Mount Sinai Morningside-West.
Katherine Loomba matched with Internal Medicine at Dartmouth Hitchcoking Medical Center.
Julie To Cherry matched with Pediatric at Dartmouth.
March 22th, 2023:
Dr. Zhang and his DO/Ph.D students, Ashwin and Manny, published a review entitled Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights in Frontiers: Cell and Developmental Biology.
March 9, 2023:
Dr. Zhang patented Methods for treating cancer by disabling BRCA1/FANCM interactions. For more information on the methods and patent itself click on:
https://patents.google.com/patent/US20210180056A1/en
February 27th, 2023:
Dr. Zhang and his scholar students, Noelle and Sanket, published a review on Hutchinson-Gilford Progeria in Genes special issue DNA Replication/Repair, and the DNA Damage in Human Disease.
November 18th, 2022:
Dr. Zhang and his colleagues at New York Medical College and Fordham University published an article regarding identifying immunogenic proteins through Western blot analysis for developing a vaccine for Lyme disease.
October 19th, 2022:
Dr. Zhang and his colleagues at New York Medical College published a review article in Genes regarding POLDIP3 role in RNA and DNA metabolism.
October 14th, 2022:
Dr. Zhang and his students (Manrose Singh, D.O/PhD Candidate; Danny MacKenzie, D.O; Sanket Desai, Research Scholar; and Noelle Batista, Academic Scholar) published an article in Precision Medicine regarding novel molecular targets for treating ALT-Positive cancers.
September 27th, 2022:
Dr. Zhang and colleagues from New York Medical College published an Original Article on DNA polymerase delta affects biological function in vivo in relation to DNA damage response.
August 4th, 2022:
Dr. Zhang's Ph.D./DO student, Manrose (Manny) Singh, passed his Dissertation proposal.
July 10th, 2022:
Dr. Zhang's Ph.D./DO student, Manrose (Manny) Singh, was selected to give an oral presentation at the Gordon Research Conference (GRC) on Genomic Instability in Ventura CA in July of 2022. The GRC is designed to address both the fundamental mechanisms and translational impact of the cellular pathways that maintain genome stability. Genomic instability contributes to development of many human diseases, such as cancer, neurodegeneration, and premature aging. This conference will present the latest research on the molecular causes of genomic instability in various human conditions, ranging from DNA replication defects to R-loop biogenesis. We will also cover the cutting-edge findings of DNA repair and DNA damage signaling pathways, their roles in counteracting different forms of genomic instability, and their deficiencies in human diseases. Manny presented his research regarding emerging DNA repair pathways.
Page updated
Report abuse